FDA seeks distance from “parasitic-Canada” comment
AUTOR(ES)
Whitwham, Brian
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=191319Documentos Relacionados
- FDA seeks to ease burden on trial review boards
- New law aims to distance the FDA from the drug industry
- Vioxx: lessons for Health Canada and the FDA
- “New approach” as Health Canada seeks conditional licences for drugs, new pediatric office
- US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada